Tetrahydrocannabiphorol
Tetrahydrocannabiphorol is a potent phytocannabinoid, a CB1 and CB2 receptor agonist which was known as a synthetic homologue of tetrahydrocannabinol, but for the first time in 2019 was isolated as a natural product in trace amounts from Cannabis sativa.
THCP is structurally similar to Δ9-THC, the main active component of cannabis, but with the pentyl side chain extended to heptyl. Since it has a longer side chain, its cannabinoid effects are "far higher than Δ9-THC itself." Tetrahydrocannabiphorol has a reported binding affinity of 1.2 nM at CB1, approximately 33 times that of Δ9-THC, however this does not mean it's 33x stronger per milligram.
THCP was studied by Roger Adams as early as 1942.
Isomers
Delta-3-THCP
]The Δ3/Δ6a isomer Δ3-THCP was synthesised in 1941, and was found to have around the same potency as Δ3-THC, unlike the hexyl homologue parahexyl which was significantly stronger.